Source: MVS Noticias

The company Sanofi Aventis filed a complaint for counterfeiting of the Plaquenil product.

The Federal Commission for the Protection against Sanitary Risks (Cofepris) issued a health alert for the counterfeiting of the drug hydroxychloroquine, marketed under the name Plaquenil.

In a statement, he explained that the company Sanofi Aventis filed a complaint for the falsification of the product Plaquenil in its presentation of 200 milligram tablets and warned that this product does not contain the active ingredient hydroxychloroquine , instead microcrystalline cellulose was identified , and the box There are differences in the printing of the price, the font used in the texts and the color.

Related:

Mexico to administer hydroxychloroquine to 20,000

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/ azithromycin and other regimens in Marseille, France: A retrospective analysis

How a False Hydroxychloroquine Narrative Was Created. “Dangerous” When Used for Covid-19

National Cancer Instititute: List of Active Clinical Trials Using Hydroxychloroquine for Cancer

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »